DEFINITIVE PROXY STATEMENT

Company

FILANA THERAPEUTICS, INC.

Filed

April 18, 2001

Period of Report

May 31, 2001

Accession Number

0001095811-01-501338

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →